Glucagon and Joint swelling - a phase IV clinical study of FDA data

Summary:

Joint swelling is reported as a side effect among people who take Glucagon (glucagon hydrochloride), especially for people who are female, 60+ old, also take Lyrica, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Joint swelling when taking Glucagon. It is created by eHealthMe based on reports of 4,289 people who have side effects when taking Glucagon from the FDA, and is updated regularly.

What is Glucagon?

Glucagon has active ingredients of glucagon hydrochloride. eHealthMe is studying from 4,297 Glucagon users. Check the latest studies of Glucagon.

What is Joint swelling?

Joint swelling is found to be associated with 2,120 drugs and 2,938 conditions by eHealthMe. Check the latest studies of Joint swelling.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

4,289 people reported to have side effects when taking Glucagon.
Among them, 12 people (0.28%) have Joint swelling.

Among these 12 people:

What is the gender of people who have Joint swelling when taking Glucagon? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Joint swelling when taking Glucagon? *

What are other drugs people take besides Glucagon? *

What are other side effects people have besides Joint swelling? *

Pain: 9 people, 75.00%
Urinary Tract Infection: 7 people, 58.33%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 58.33%
Fall: 7 people, 58.33%
High Blood Pressure: 6 people, 50.00%
Joint Pain: 6 people, 50.00%
Acute Kidney Failure: 6 people, 50.00%
Hypotension (abnormally low blood pressure): 6 people, 50.00%
Dehydration (dryness resulting from the removal of water): 6 people, 50.00%
Fever: 5 people, 41.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 41.67%
Type 2 Diabetes: 4 people, 33.33%
Pain: 4 people, 33.33%
Osteoporosis (bones weak and more likely to break): 4 people, 33.33%
Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
Back Pain: 2 people, 16.67%
Type 1 Diabetes: 2 people, 16.67%
Iron Deficiency Anaemia: 2 people, 16.67%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 16.67%
Parkinson's Disease: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Glucagon and have Joint swelling?

- Check whether Joint swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glucagon:

Glucagon (4,297 reports)

Joint swelling treatments and more:

Joint swelling (143,797 reports)

Browse all side effects of Glucagon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint swelling:

Joint swelling (2,120 drugs)

Browse all the conditions that are associated with Joint swelling:

Joint swelling (2,938 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glucagon hydrochloride (the active ingredients of Glucagon) and Glucagon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.